Tate & Lyle To Expand Singapore Biopolis Laboratory

Wednesday, November 2nd, 2016 | 824 Views


The ingredients provider expects to more than double the size of its current Singapore laboratory with new facilities such as a pilot plant with scale food processing equipment.

Reflecting the company’s shift towards specialty ingredients, the investment in its Biopolis plant will also give wider analytical capabilities, including updated technology to predict shelf life for products, which will help reduce product development time.

Tate & Lyle this year recorded a five percent rise in global profits, after a fluctuating few years of trading.

The lab expansion is due for completion by the end of the first quarter of 2017.

The company is also shifting away from sucralose, due to falling global profit margins. It previously closed its Singapore sucralose site in 2015.

 

Further reading:

New Managing Director At Montgomery Asia
Combatting The Allergy Issue
Nestlé Launches YES! Snack Bars In Recyclable Paper Wrapper
Palsgaard Achieves Total Carbon-Neutral Production
Consumers Want More Protein, Boosting Market To Reach US$46.8 Billion
Consumers Want Protein With Clean Labels
Roquette Acquires Itacel To Boost Its Pharmaceutical Portfolio
Kalsec Mildenhall UK Facility Receives British Retail Consortium (BRC) AA Rating
Asia: Major Driver Of Protein Consumption
Mocon Appoints New Senior Vice President Of Global Sales And Marketing

WANT MORE INSIDER NEWS? SUBSCRIBE TO OUR DIGITAL MAGAZINE NOW!

 

SHARE WITH FRIENDS: